Mometasone Furoate Monohydrate Spray, Metered
Product Images NDC 59651-402

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Mometasone Furoate Monohydrate (NDC 59651-402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Mometasone Fig1)

An instructional illustration showing the components of a nasal spray device for Mometasone Furoate Monohydrate spray, metered, nasal. It depicts a plastic cap being removed from the nasal applicator attached to the bottle.*

FDA Label Image

Fig10 (Mometasone Fig10)

An instructional illustration depicting a hand holding a nasal spray bottle labeled as Mometasone Furoate Monohydrate 50 mcg/1 spray. The image shows the correct grip and direction to press the pump for administering the nasal spray.*

FDA Label Image

Fig11 (Mometasone Fig11)

An instructional illustration showing a hand pressing the nozzle of a nasal spray bottle, labeled as Figure 11. The image demonstrates the use of a metered nasal spray device, consistent with the Mometasone Furoate Monohydrate spray dosage form.*

FDA Label Image

Package Label-principal Display Panel (50 mcg Container Label (120 Metered Sprays))

Mometasone Furoate Monohydrate Nasal Spray 50 mcg label by Aurobindo Pharma Limited. The label indicates 120 metered sprays per 17 g bottle for intranasal use only. It includes storage instructions, usage precautions, and distributor information for Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (50 mcg Container Carton Label (120 Metered Sprays))

The packaging label for Mometasone Furoate Monohydrate Nasal Spray, 50 mcg per spray, a metered-dose nasal spray by Aurobindo Pharma Limited. The label states 120 metered sprays with a net content of 17 g, intended for intranasal use only as a scent-free mist. It includes pharmacy and patient instructions, storage conditions, dosage guidelines, and contact information for more details. The label also displays barcodes and the NDC number 59651-402-17.*

FDA Label Image

Fig2 (Mometasone Fig2)

An instructional line drawing illustrating a hand holding a metered nasal spray bottle labeled as Mometasone Furoate Monohydrate 50 ug. The image shows the positioning for use, with an arrow indicating downward direction on the spray nozzle.*

FDA Label Image

Fig3 (Mometasone Fig3)

An instructional line drawing showing a person using a nasal spray. The individual is holding the spray bottle with one hand near the nostril while pressing the nozzle with the other hand, demonstrating proper administration technique for a nasal spray product.*

FDA Label Image

Fig4 (Mometasone Fig4)

An instructional illustration showing proper use of the Mometasone Furoate Monohydrate nasal spray. The image depicts a person holding the spray bottle in an upright position with one hand while aiming the nozzle into their nostril. An arrow indicates the direction of spray use. Text emphasizes keeping the spray upright to ensure a complete dose.*

FDA Label Image

Fig5 (Mometasone Fig5)

An instructional illustration showing a hand holding a metered nasal spray with a labeled plastic cap, highlighting the cap removal or placement on the spray bottle for a product similar to Mometasone Furoate Monohydrate nasal spray.*

FDA Label Image

Fig6 (Mometasone Fig6)

An instructional diagram depicting a nasal spray device assembly. The image identifies a white nasal applicator positioned above a pump stem attached to a bottle, indicating how the applicator fits onto the pump stem for use.*

FDA Label Image

Fig7 (Mometasone Fig7)

An instructional illustration showing use of a white nasal applicator for a metered nasal spray. The diagram highlights the applicator part of the device and depicts the spray being emitted, labeled as Figure 7.*

FDA Label Image

Fig8 (Mometasone Fig8)

An illustration labeled Figure 8 showing a hand holding a metered nasal spray bottle with a plastic cap. The cap is indicated by a label pointing to it, and dashed arrows suggest the cap's removal direction.*

FDA Label Image

Fig9 (Mometasone Fig9)

A black and white labeled diagram showing parts of a nasal spray bottle. It identifies the center hole, white nasal applicator, and pump stem on the bottle, illustrating the components of the nasal spray device.*

FDA Label Image

Structure (Mometasone Str)

Chemical structure diagram of mometasone furoate monohydrate showing its steroid framework with chlorine and furoate ester functional groups, including the hydrate component (H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.